BillionToOne
BillionToOne develops molecular diagnostics that increase accessibility to vital health information through their unique quantitative counting technology. Their tests, including prenatal screenings, offer precise, actionable insights for clinicians and patients.Content by BillionToOne
Filter by
AllArticlesAudioEbooksEventsInfographicsNewsProductsSurveysDocumentsVideosVirtual EventsWebinars
The BillionToOne COVID-19 test uses different sets of instruments and chemicals from existing COVID-19 tests, enabling labs to unlock a new set of unused capacity
| 2 min read
Page 1 of 1 - 1 Total Items
